Catalyst Pharmaceutical Partners shares owned by Legal & General Group
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Catalyst Pharmaceutical Partners by Legal & General Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 774k | 19.70 |
| 2025-06-30 | $14M | 664k | 21.70 |
| 2025-03-31 | $14M | 574k | 24.25 |
| 2024-12-31 | $7.2M | 345k | 20.87 |
| 2024-09-30 | $6.5M | 326k | 19.88 |
| 2024-06-30 | $4.7M | 305k | 15.49 |
| 2024-03-31 | $4.9M | 310k | 15.94 |
| 2023-12-31 | $4.8M | 288k | 16.81 |
| 2023-09-30 | $3.4M | 288k | 11.69 |
| 2023-06-30 | $3.8M | 281k | 13.44 |
| 2023-03-31 | $4.0M | 240k | 16.58 |
| 2022-12-31 | $4.5M | 240k | 18.60 |
| 2022-09-30 | $2.9M | 227k | 12.83 |
| 2022-06-30 | $265k | 38k | 7.01 |
| 2022-03-31 | $289k | 35k | 8.29 |
| 2021-12-31 | $236k | 35k | 6.78 |
| 2021-09-30 | $187k | 35k | 5.38 |
| 2021-06-30 | $87k | 15k | 5.68 |
| 2021-03-31 | $114k | 25k | 4.64 |
| 2020-12-31 | $46k | 14k | 3.37 |
| 2020-09-30 | $41k | 14k | 2.95 |
| 2020-06-30 | $84k | 18k | 4.64 |
| 2020-03-31 | $66k | 17k | 3.85 |
| 2019-12-31 | $81k | 22k | 3.77 |
| 2019-09-30 | $121k | 23k | 5.29 |
| 2019-06-30 | $93k | 24k | 3.84 |
| 2019-03-31 | $75k | 15k | 5.09 |
| 2018-12-31 | $28k | 15k | 1.90 |
| 2018-09-30 | $56k | 15k | 3.80 |
| 2018-06-30 | $46k | 15k | 3.12 |
| 2018-03-31 | $37k | 15k | 2.40 |
| 2017-12-31 | $67k | 17k | 3.93 |
| 2017-09-30 | $27k | 11k | 2.55 |
| 2017-06-30 | $29k | 11k | 2.74 |
| 2016-03-31 | $12k | 10k | 1.15 |
| 2015-12-31 | $26k | 10k | 2.50 |
| 2015-09-30 | $31k | 10k | 2.98 |
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners